Vital Images to use iCAD technology
This article was originally published in The Gray Sheet
Executive Summary
iCAD's Second Look CT computer-aided detection (CAD) will be integrated, pending FDA approval, into the firm's Vitrea 2 medical imaging software for diagnostic evaluation of CT and MR image data to detect polyps that could lead to colon cancer under a non-exclusive agreement. Vital Images inked a July deal with CAD-competitor R2 Technology to incorporate the latter firm's ImageChecker CT system with Vitrea 2 for lung nodules (1"The Gray Sheet" July 19, 2004, p. 22). Vital Images is a distributor for R2...
You may also be interested in...
R2 ImageChecker Approval Launches CAD Lung Market; iCAD Preps To Join
FDA approval of R2 Technology's ImageChecker CT CAD system for lung nodules July 8 provides the firm with a comfortable head-start over competitor iCAD, which expects to launch its own system in 2005
Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
Hair Supplement Linked To Cases Of Severe Hepatitis In France
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: